和厚朴酚通过诱导RIP1非依赖的非经典性程序性坏死克服肿瘤多药耐药与凋亡耐受

来源 :华东抗肿瘤药物研究新进展与肿瘤精准治疗论坛 | 被引量 : 0次 | 上传用户:apworld
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Background: Honokiol is a pharmacologically active small molecule with multifunctional antitumor effects.Although plenty of literature is available on honokiol-triggered apoptosis and programmed necrosis,few studies have investigated the potential existence of death mode transition from apoptosis to programmed necrosis.
其他文献
An increasing number of studies reveal the significance of genetic markers in guiding target treatment and refining prognosis.This study aims to assess the mutation profile of metastatic colorectal ca
会议
Introduction: Fluoropyrimidine and oxaliplatin are widely used for patients with colorectal cancer.
Purpose:To understand the suppressive role of osthole on the transforming growth factor-β1(TGF-β1)-induced epithelial-mesenchymal transition(EMT)and its role in lung cancer migration and invasion.
Objective: Tanshinones,the lipid-soluble constituents,were separated from the root of Salvia miltiorrhiza Bunge(Danshen).
Objective: To investigate the effect and possible mechanism of TO901317,an agonist of Liver X receptors(LXRs),on the proliferation and invasion of breast cancer cells.
背景与目的:探讨盐酸注射结合射频消融(HCl+RFA)的不同消融时间、盐酸浓度、盐酸预注射量对消融范围的影响。 方法:采用新鲜的离体牛肝作为研究对象,将实验分为 3 组:A 组,时间变量组:2ml3mol/L 盐酸预注射后不同射频消融时间(15min、30min、45min)组。
目的:为探讨增强射频消融的辅助方式,研究 38.5%氯化钠(NaCl)溶液和 10%盐酸(HCl)溶液预注射对射频消融的导电性、温度和消融范围的影响. 材料与方法:采用新鲜的离体牛肝作为研究对象,将实验分为三组:射频消融组(RFA 组);38.5%NaCl 溶液预注射射频消融组(NaCl-RFA 组);10%HCl 溶液预注射射频消融组(HCl-RFA 组).
Background: Gastric cancer is the fourth most common cancer in the world.The development of both chemotherapy and targeted drugs are limited due to the complexity of gastric cancer.Methods: SRB and co
Objective: Most non-small cell lung cancer(NSCLC)patients responding to gefitinib harbor activating mu tations in the epidermal growth factor receptor(EGFR).Acquired resistance to gefitinib can occur
Background: The aim of our study is to evaluate the preliminary efficacy and side effects of paclitaxel,5-fluorouracil and leucovorin intravenous chemotherapy in combination with cisplatin hyperthermi